** = Publikationen gelistet in SCI/SSCI/Pubmed
** Ristić, D; Bärnthaler, T; Gruden, E; Kienzl, M; Danner, L; Herceg, K; Sarsembayeva, A; Kargl, J; Schicho, R
GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis.
Front Immunol. 2024; 15: 1513547
Doi: 10.3389/fimmu.2024.1513547
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kienzl, M; Maitz, K; Sarsembayeva, A; Valadez-Cosmes, P; Gruden, E; Ristic, D; Herceg, K; Kargl, J; Schicho, R
Comparative Study of the Immune Microenvironment in Heterotopic Tumor Models.
Cancers (Basel). 2024; 16(2):
Doi: 10.3390/cancers16020295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gruden, E; Kienzl, M; Hasenoehrl, C; Sarsembayeva, A; Ristic, D; Schmid, ST; Maitz, K; Taschler, U; Hahnefeld, L; Gurke, R; Thomas, D; Kargl, J; Schicho, R
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles.
Prostaglandins Leukot Essent Fatty Acids. 2023; 196: 102585
Doi: 10.1016/j.plefa.2023.102585
Web of Science
PubMed
FullText
FullText_MUG
** Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Maitz, K; Valadez-Cosmes, P; Santiso, A; Hasenoehrl, C; Brcic, L; Lindenmann, J; Kargl, J; Schicho, R
Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells.
Front Immunol. 2022; 13:997115
Doi: 10.3389/fimmu.2022.997115
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sarsembayeva, A; Schicho, R
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
Front Oncol. 2023; 13: 1296906
Doi: 10.3389/fonc.2023.1296906
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gruden, E; Pammer, A; Kienzl, M; Sarsembayeva, A; Ristic, D; Schicho, R
The role of the Cannabinoid receptor 2 (CB2) in T regulatory cell differentiation and function.
EUR J IMMUNOL. 2022; 52: 264-264.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
** Kienzl, M; Gruden, E; Sarsembayeva, A; Maitz, K; Ristic, D; Valadez-Cosmes, P; Kargl, J; Schicho, R
CRTH2 as a pro-tumorigenic driver in the tumor microenvironment of experimental models of colon cancer
EUR J IMMUNOL. 2022; 52: 281-281.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
** Ristic, D; Kienzl, M; Sarsembayeva, A; Gruden, E; Kargl, J; Schicho, R
Pro-tumorigenic role of GPR55 in the immune microenvironment of pancreatic cancer
EUR J IMMUNOL. 2022; 52: 291-291.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Poster]
Web of Science
** Sarsembayeva, A; Kienzl, M; Gruden, E; Ristic, D; Kargl, J; Schicho, R
Cannabinoid receptor 2 creates a suppressive tumor immune microenvironment in a mouse model of lung cancer and predicts responsiveness to anti-PD-1 antibody treatment
EUR J IMMUNOL. 2022; 52: 78-79.-Joint meeting DFGI & ÖGAI; SEPT 7-10, 2022; Hannover, Germany.
[Oral Communication]
Web of Science
FullText
** Kienzl, M; Hasenoehrl, C; Maitz, K; Sarsembayeva, A; Taschler, U; Valadez-Cosmes, P; Kindler, O; Ristic, D; Raftopoulou, S; Santiso, A; Bärnthaler, T; Brcic, L; Hahnefeld, L; Gurke, R; Thomas, D; Geisslinger, G; Kargl, J; Schicho, R
Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer.
Oncoimmunology. 2021; 10(1): 1965319
Doi: 10.1080/2162402X.2021.1965319
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kienzl, M; Hasenoehrl, C; Valadez-Cosmes, P; Maitz, K; Sarsembayeva, A; Sturm, E; Heinemann, A; Kargl, J; Schicho, R
IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils.
ONCOIMMUNOLOGY. 2020; 9(1): 1776059
Doi: 10.1080/2162402X.2020.1776059
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG